Subscribe to Updates in Healthcare

RSS By Email

RSS By RSS

Add to Google Reader or Homepage

Subscribe in Bloglines


The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.Learn more about GLG's Compliance Framework


This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
Find Out More

Keith Allen, MD

Keith Allen, MD, Director, Cardiothoracic Vascular Surgery Research, Mid America Heart & Lung Surgeons, PCDirector, Cardiothoracic Vascular Surgery Research
Mid America Heart & Lung Surgeons, PC
Member of the Healthcare Council

Keith Allen, MD, is a Director of Cardiothoracic-Vascular Surgery Research at the Mid America Heart Institute in Kansas City, Missouri. He is board certified in Thoracic, Vascular, and General Surgery. Dr. Allen maintains an active clinical research department and has over 100 publications in journals such as the NEJM, JTCVS, and The Annals of Thoracic Surgery. He is serving on the FDA's Circulatory Device Panel. Additionally, Dr. Allen continues to advise companies on clinical study design, Medicare reimbursement issues, and FDA regulatory process including two successful PMA presentations to the FDA device panel as the lead presenter. He is a Fellow of the American College of Surgeons and a member of American Association of Thoracic Surgeons (AATS), Society of Thoracic Surgery (STS), and the International Society for Minimally Invasive Surgery (ISMICS). (This is me - Update Profile)


Employment History
2007 - present Director, Cardiothoracic Vascular Surgery Research
Mid America Heart & Lung Surgeons, PC
1994 - 2007 Surgeon
Corvasc Md's PC

GLG NewsSM Analyses by Keith Allen, MD(?)

Opinions and analyses expressed in GLG News are solely those of the author. See the Terms of Use for details.
Drug Eluting Stents:The Next Vioxx | 12-14-2006
Author: Keith Allen, MD, Director, Cardiothoracic Vascular Surgery Research, Mid America Heart & Lung Surgeons, PC

1. DES whether used on or off label will likely require life long anticoagulation with Plavix like drugs.2. The incidence of late thrombosis is significant when anticoagulation is interrupted for events such as elective surgery.3. Unlike restenosis following insertion of a bare metal stent...

GLG InstituteSM Seminars with Keith Allen, MD(?)

 
Keith Allen, MD has not participated in any GLGi Seminars.
View all GLG InstituteSM Seminars in Healthcare

Request a project with Keith Allen, MD









Note: GLG Experts do not provide personal medical advice, diagnosis or treatment through this site.

GLG's 750+ Clients Include:

40 of the leading 50
global mutual funds
15 of the leading 20
global banks
8 of the leading 10
private equity firms
90%+ client subscription renewal rate

Analytics


Generated at 2008-11-19T05:45:17.993